AngioDynamics (FRA:UG2) Debt-to-Asset : 0.02 (As of Aug. 2024)

View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Debt-to-Asset?

AngioDynamics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was €4.4 Mil. AngioDynamics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2024 was €0.0 Mil. AngioDynamics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Aug. 2024 was €266.3 Mil. AngioDynamics's debt to asset for the quarter that ended in Aug. 2024 was 0.02.

AngioDynamics Debt-to-Asset Historical Data

The historical data trend for AngioDynamics's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Debt-to-Asset Chart

AngioDynamics Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

Debt-to-Asset

Get a 7-Day Free Trial

0.07

0.04

0.06

0.12

0.02

AngioDynamics Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Debt-to-Asset	Get a 7-Day Free Trial															0.01	-	-	0.02	0.02

Competitive Comparison of AngioDynamics's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, AngioDynamics's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AngioDynamics's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where AngioDynamics's Debt-to-Asset falls into.

AngioDynamics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

AngioDynamics's Debt-to-Asset for the fiscal year that ended in May. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4.373	+	0)	/	293.846
	=	0.01

AngioDynamics's Debt-to-Asset for the quarter that ended in Aug. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4.357	+	0)	/	266.321
	=	0.02

AngioDynamics (FRA:UG2) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

AngioDynamics Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of AngioDynamics's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

ANGO:USA UG2:Germany

Address

14 Plaza Drive, Latham, NY, USA, 12110

Website

https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

AngioDynamics Headlines

No Headlines